abrdn plc — 2025 Investments

2 investments dated 2025 · listed companies and verified rows first · show all

Atalantaatalantatx.com in 𝕏Jan 2025 · $97M

Atalanta is developing treatment options for intractable central nervous system diseases using RNA interference technology.

BiotechDeep TechHealthtechMedical Devices

Co-investorsF-Prime Capital Novartis Venture Fund RiverVest Venture Partners Sanofi Ventures EQT Life Sciences

Matter Real Estatematterrealestate.co.uk inJan 2025

Matter is a real estate investment firm focused on the living sector, investing across sub-sectors such as single- and multi-family, senior living, and affordable housing.

Impact & Social GoodPropTech

David Christie(CEO)in

Co-investorsBlack Lion Ventures GCM Grosvenor UBS

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.